TelyRx Holdings Inc. experienced a notable uptick in its stock price during yesterday's trading session.
TelyRx Holdings Inc. saw its stock rise by 5.66% yesterday, closing at CA$2.80. This increase comes as the company continues to expand its operations and improve its financial performance, making it a notable gainer on the TSX.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$70.43M
52W high
$4.25
52W low
$2.00
1W change
-3.45%
Analyst Price Targets
Based on analyst covering TELY
Wall Street analysts forecast TELY stock price to rise 114.3% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+114.3% Upside
Current Price
C$2.80
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
95.4%
Annualized
90-Day Vol
97.1%
Annualized
Trend (90d)
-42.7%
Annualized drift
90d Mean
C$2.40
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$2.66 | C$1.91 โ C$3.70 |
| 60 trading days | C$2.53 | C$1.59 โ C$4.03 |
| 90 trading days | C$2.40 | C$1.36 โ C$4.25 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors may view TelyRx's recent surge as a positive indicator of its growth potential, particularly in the digital healthcare sector.
TelyRx Stock Climbs 5.66%
With a market cap of CA$74.4 million, TelyRx's stock performance reflects growing investor confidence in its business model and market position.
Bull case
The company is strategically expanding in Clearwater, Florida, and its rising prescription fulfillment rates suggest thereโs strong demand for its services. This could lead to significant revenue growth in the future.
Bear case
However, TelyRx's negative profit margin raises concerns about its profitability. Investors looking for sustainable growth might find this troubling, as ongoing profitability issues could affect future performance.
Strong Performance in the Market
TelyRx's stock increased significantly yesterday, reflecting a positive market reaction to its operational strategies. The company's focus on expanding its Clearwater headquarters has positioned it to meet the rising demand for digital healthcare solutions, which is becoming increasingly relevant in today's market.
Financial Growth Indicators
Recent financial reports indicate a substantial increase in revenue, with TelyRx announcing a revenue of CA$42.9 million for the year ended December 31, 2025. This marks a significant jump from CA$9.5 million in 2024, showcasing the company's growth trajectory. Investors are likely encouraged by these figures, as they suggest a robust business model.
Challenges Ahead
Despite the positive stock movement, TelyRx faces challenges, particularly with its current profit margin sitting at -0.1817. Investors should remain cautious, as ongoing profitability issues could impact future performance. Monitoring the company's ability to convert revenue growth into sustainable profits will be crucial.
Advertisement
